Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...

A personalized mRNA vaccine may change melanoma treatment, with 70% of patients cancer-free after 5 years. Discover how this ...

Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...

The Wisconsin senator said at the hearing there were over 39,000 deaths worldwide associated with the COVID-19 injection.

Andrew L. Pecora, MD, discusses the significance of the long-term findings from the KEYNOTE-942 trial of intismeran autogene ...

The global veterinary vaccines market is projected to grow from USD 11 billion in 2025 to USD 15.6 billion by 2031, ...

J&J's Rybrevant and cancer vaccines are showing benefit During the American Society of Clinical Oncology (ASCO) meeting 2026, ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

Adding intismeran autogene to pembrolizumab reduces the risk of relapse and distant metastasis in patients with resected high ...

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a new class of genetic medicines for rare ...